Clinical Trial Update: The Effect of Biktarvy (B/F/TAF) on Whole-body Insulin Sensitivity, Lipid and Endocrine Profile in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 results report on the metabolic and endocrine effects of Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) on insulin sensitivity and lipid pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE)

Snippet

Sponsor: Chelsea and Westminster NHS Foundation Trust | Conditions: HIV-1-infection | Phase 1 | Status: COMPLETED